FDA Approves Opioid Overdose Drug Naloxone From Nonprofit Company

Naloxone available here stickers are pictured during at Bathgate Fire Station in Bathgate, Scotland, on Feb. 9, 2022. Jeff J Mitchell-Pool/Getty Images

The Food and Drug Administration (FDA) on Friday approved an opioid overdose drug for over-the-counter (OTC) use from a nonprofit company.

The FDA has granted approval to RiVive, manufactured by Harm Reduction Therapeutics, making it the second OTC naloxone product authorized this year.